Nautilus Biotechnology Inc (NAUT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 15,472 | 17,097 | 18,844 | 19,980 | 19,100 |
| Operating Income | -15,472 | -17,097 | -18,844 | -19,980 | -19,100 |
| Other Income | 1,898 | 2,064 | 2,231 | 2,386 | 2,654 |
| Pre-tax Income | -13,574 | -15,033 | -16,613 | -17,594 | -16,446 |
| Net Income Continuous | -13,574 | -15,033 | -16,613 | -17,594 | -16,446 |
| Net Income | $-13,574 | $-15,033 | $-16,613 | $-17,594 | $-16,446 |
| EPS Basic Total Ops | -0.11 | -0.12 | -0.13 | -0.14 | -0.13 |
| EPS Basic Continuous Ops | -0.11 | -0.12 | -0.13 | -0.14 | -0.13 |
| EPS Diluted Total Ops | -0.11 | -0.12 | -0.13 | -0.14 | -0.13 |
| EPS Diluted Continuous Ops | -0.11 | -0.12 | -0.13 | -0.14 | -0.13 |
| EPS Diluted Before Non-Recurring Items | -0.11 | -0.12 | -0.13 | -0.14 | -0.13 |
| EBITDA(a) | $-14,159 | $-15,903 | $-17,760 | $-19,055 | $-18,211 |